TruScreen Group Limited successfully secured a tender for the supply of a further 10,800 SUS (Single Use Sensor) which is expected to be shipped in March 2023. The TruScreen cervical cancer screening roll out in Zimbabwe continues to make excellent progress with the programme scanning 10,500 women in the Masvingo province at the end of January 2023. TruScreen continues to work closely with the National Aids Council and the Ministry of Health in support of its plan to implement the programme nationally.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.019 NZD | 0.00% | +5.56% | -17.39% |
30/05 | TruScreen Group Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
30/05 | Truscreen's Fiscal Year 2024 Loss Widens | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.39% | 64.9L | |
+8.38% | 22TCr | |
+15.78% | 20TCr | |
+31.27% | 11TCr | |
+4.33% | 6.62TCr | |
+14.19% | 5.25TCr | |
+4.70% | 5.08TCr | |
-3.93% | 3.9TCr | |
-0.47% | 3.51TCr | |
+23.96% | 3.13TCr |
- Stock Market
- Equities
- TRU Stock
- News TruScreen Group Limited
- TruScreen Group Limited Secures Tender for the Supply of A Further 10,800 SUS